DK658688D0 - 1-aryl-3-quinolin- og 1-aryl-3-isoquinolin-carboxamider, deres fremstilling og anvendelse som laegemidler - Google Patents
1-aryl-3-quinolin- og 1-aryl-3-isoquinolin-carboxamider, deres fremstilling og anvendelse som laegemidlerInfo
- Publication number
- DK658688D0 DK658688D0 DK658688A DK658688A DK658688D0 DK 658688 D0 DK658688 D0 DK 658688D0 DK 658688 A DK658688 A DK 658688A DK 658688 A DK658688 A DK 658688A DK 658688 D0 DK658688 D0 DK 658688D0
- Authority
- DK
- Denmark
- Prior art keywords
- aryl
- quinoline
- preparation
- medicinal products
- isoquinoline carboxamides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/125,971 US4786644A (en) | 1987-11-27 | 1987-11-27 | 1-aryl-3-quinolinecarboxamide |
Publications (2)
Publication Number | Publication Date |
---|---|
DK658688D0 true DK658688D0 (da) | 1988-11-25 |
DK658688A DK658688A (da) | 1989-05-28 |
Family
ID=22422331
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK658688A DK658688A (da) | 1987-11-27 | 1988-11-25 | 1-aryl-3-quinolin- og 1-aryl-3-isoquinolin-carboxamider, deres fremstilling og anvendelse som laegemidler |
Country Status (5)
Country | Link |
---|---|
US (1) | US4786644A (da) |
EP (1) | EP0317991A3 (da) |
JP (1) | JPH02138260A (da) |
DK (1) | DK658688A (da) |
PT (1) | PT89094B (da) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3576686D1 (de) * | 1984-08-15 | 1990-04-26 | Boots Co Ltd | Chinolinone, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen praeparate. |
US4959363A (en) * | 1989-06-23 | 1990-09-25 | Sterling Drug Inc. | Quinolonecarboxamide compounds, their preparation and use as antivirals. |
EP0612729B1 (en) * | 1991-05-10 | 1997-04-23 | Takeda Chemical Industries, Ltd. | Pyridine derivatives, their production and use |
US5514678A (en) * | 1992-03-26 | 1996-05-07 | E. I. Du Pont De Nemours And Company | Arthropodicidal 1,2,4-triazinyl amides |
EP0841929B1 (en) * | 1995-08-02 | 2003-05-07 | Darwin Discovery Limited | Quinolones and their therapeutic use |
EP0841927B1 (en) * | 1995-08-02 | 2004-01-28 | Darwin Discovery Limited | Quinolones and their therapeutic use |
US5945431A (en) * | 1996-03-15 | 1999-08-31 | Biochem Therapeutics Incorporated | Cytomegalovirus inhibiting compounds |
GB9605437D0 (en) * | 1996-03-15 | 1996-05-15 | Iaf Biochem Int | Cytomegalovirus inhibiting compounds |
KR20010033405A (ko) * | 1997-12-22 | 2001-04-25 | 로렌스 티.마이즌 헬더. | 4-히드록시퀴놀린-3-카르복스아미드 및 히드라지드항바이러스제 |
US6248736B1 (en) * | 1999-01-08 | 2001-06-19 | Pharmacia & Upjohn Company | 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
WO2002049632A1 (fr) * | 2000-12-18 | 2002-06-27 | Institute Of Medicinal Molecular Design. Inc. | Inhibiteurs de production et de liberation de cytokines inflammatoires |
US20100074949A1 (en) | 2008-08-13 | 2010-03-25 | William Rowe | Pharmaceutical composition and administration thereof |
DE10222895A1 (de) * | 2002-05-23 | 2003-12-11 | Bosch Gmbh Robert | Hochdruckspeicher für Kraftstoffeinspritzsysteme mit integriertem Druckregelventil |
JPWO2003103647A1 (ja) * | 2002-06-05 | 2005-10-06 | 株式会社医薬分子設計研究所 | Ap−1及びnfat活性化阻害剤 |
CN100379410C (zh) * | 2002-06-05 | 2008-04-09 | 株式会社医药分子设计研究所 | 糖尿病治疗药 |
US20060019958A1 (en) * | 2002-06-05 | 2006-01-26 | Susumu Muto | Immunity-related protein kinase inhibitors |
WO2003103656A1 (ja) * | 2002-06-06 | 2003-12-18 | 株式会社医薬分子設計研究所 | O−置換ヒドロキシアリール誘導体 |
EP1514544A4 (en) * | 2002-06-06 | 2009-01-07 | Inst Med Molecular Design Inc | HYPO-ALLERGENIC |
WO2003103655A1 (ja) * | 2002-06-10 | 2003-12-18 | 株式会社医薬分子設計研究所 | 癌治療剤 |
CA2489091A1 (en) * | 2002-06-10 | 2003-12-18 | Institute Of Medicinal Molecular Design, Inc. | Inhibitors against activation of nf-kappab |
WO2003103657A1 (ja) * | 2002-06-11 | 2003-12-18 | 株式会社医薬分子設計研究所 | 神経変性疾患治療剤 |
CN100417847C (zh) * | 2002-11-12 | 2008-09-10 | Nok株式会社 | 橡胶状弹性部件 |
TW200505450A (en) * | 2003-02-03 | 2005-02-16 | Janssen Pharmaceutica Nv | Quinoline-derived amide modulators of vanilloid VR1 receptor |
EP2502912A3 (en) * | 2004-06-24 | 2013-11-06 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
US8354427B2 (en) | 2004-06-24 | 2013-01-15 | Vertex Pharmaceutical Incorporated | Modulators of ATP-binding cassette transporters |
RU2525115C2 (ru) * | 2004-06-24 | 2014-08-10 | Вертекс Фармасьютикалз Инкорпорейтед | Способ модуляции транспортеров атф-связывающей кассеты |
MX2007000095A (es) * | 2004-06-24 | 2007-03-21 | Vertex Pharma | Moduladores de transportadores con casete de union con atp. |
CA2634113A1 (en) * | 2005-12-24 | 2007-07-05 | Vertex Pharmaceuticals Incorporated | Quinolin- 4 - one derivatives as modulators of abc transporters |
SI3219705T1 (sl) | 2005-12-28 | 2020-08-31 | Vertex Pharmaceuticals Incorporated | Farmacevtski sestavki amorfne oblike N-(2,4-bis(1,1-dimetiletil)-5- hidroksifenil)-1,4-dihidro-4-oksokinolin-3-karboksamid |
LT2821400T (lt) | 2009-03-20 | 2018-02-12 | Vertex Pharmaceuticals Incorporated | Cistinės fibrozės transmembraninio laidumo reguliatoriaus moduliatorių gamybos būdas |
PL2590949T3 (pl) * | 2010-07-09 | 2016-06-30 | Active Biotech Ab | Sposób wytwarzania chinolino-3-karboksyamidów |
US8802700B2 (en) | 2010-12-10 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-Binding Cassette transporters |
RU2692779C2 (ru) | 2012-02-27 | 2019-06-27 | Вертекс Фармасьютикалз Инкорпорейтед | Фармацевтическая композиция и ее введения |
EP2888010B1 (en) | 2012-08-22 | 2021-05-19 | Cornell University | Methods for inhibiting fascin |
WO2015127125A1 (en) | 2014-02-20 | 2015-08-27 | Cornell University | Compounds and methods for inhibiting fascin |
EP3204358B1 (en) | 2014-10-07 | 2018-09-19 | Vertex Pharmaceuticals Incorporated | Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2324304A2 (fr) * | 1975-09-22 | 1977-04-15 | Roussel Uclaf | Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament |
IE52670B1 (en) * | 1981-03-03 | 1988-01-20 | Leo Ab | Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation |
HU190796B (en) * | 1981-06-12 | 1986-11-28 | Roussel Uclaf,Fr | Process for producing n-dihydrothiazolyl-3-quinoline-carboxamide derivatives |
FR2537140B1 (fr) * | 1982-12-07 | 1986-07-18 | Roussel Uclaf | Nouveaux derives de la 4-hydroxy-3-quinoleine carboxamide, leur sels, procede de preparation, application a titre de medicaments, et compositions les renfermant |
DE3576686D1 (de) * | 1984-08-15 | 1990-04-26 | Boots Co Ltd | Chinolinone, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen praeparate. |
-
1987
- 1987-11-27 US US07/125,971 patent/US4786644A/en not_active Expired - Lifetime
-
1988
- 1988-11-24 EP EP19880119541 patent/EP0317991A3/en not_active Withdrawn
- 1988-11-25 JP JP63296374A patent/JPH02138260A/ja active Pending
- 1988-11-25 PT PT89094A patent/PT89094B/pt not_active IP Right Cessation
- 1988-11-25 DK DK658688A patent/DK658688A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPH02138260A (ja) | 1990-05-28 |
PT89094B (pt) | 1993-03-31 |
PT89094A (pt) | 1988-12-01 |
EP0317991A2 (en) | 1989-05-31 |
EP0317991A3 (en) | 1990-11-07 |
US4786644A (en) | 1988-11-22 |
DK658688A (da) | 1989-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK658688D0 (da) | 1-aryl-3-quinolin- og 1-aryl-3-isoquinolin-carboxamider, deres fremstilling og anvendelse som laegemidler | |
DK143588A (da) | Substituerede 9-amino-tetrahydroacridiner, deres fremstilling og anvendelse som laegemidler | |
DK267489A (da) | 1-deoxy-nojirimycin-derivater, deres fremstilling og anvendelse som laegemidler | |
DK139287D0 (da) | Tertiaere hydroxyalkylxanthiner, deres fremstilling og anvendelse som laegemidler | |
DK209188D0 (da) | Bifunktionelle proteiner, deres fremstilling og anvendelse som laegemiddel | |
DK55088A (da) | 3,4-dihydro-2h-benzo(b)pyraner, deres fremstilling og anvendelse som laegemidler | |
DK166590A (da) | Substituerede allylaminderivater, deres fremstilling og anvendelse som laegemidler | |
DK366888A (da) | Castanosperminestre og -glykosider, deres fremstilling og anvendelse som laegemidler | |
DK219685D0 (da) | Heterocycliske forbindelser, deres fremstilling og anvendelse som laegemidler | |
DK581586A (da) | N-(pyrrol-l-yl)-pyridinaminer, deres fremstilling og anvendelse som laegemidler | |
DK103987A (da) | Substituerede 1,3,4,9-tetrahydropyranooe3,4-baaindol-l-eddikesyrer, deres fremstilling og anvendelse som laegemidler | |
DK284688A (da) | Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler | |
DK420986A (da) | Dihydropyridin-2-hydroxyaminer, fremgangsmaade til deres fremstilling og deres anvendelse i laege-midler | |
DK614186A (da) | Substituerede piperazin-1,4-naphtalendioner, deres fremstilling og anvendelse som laegemidler | |
DK648389A (da) | Anthracylin-derivater, deres fremstilling og anvendelse som laegemidler | |
DK501888A (da) | 6-mercaptopurin-derivater, deres fremstilling og anvendelse som laegemidler | |
DK627684D0 (da) | 1,4-naphthoquinolinderivater, deres fremstilling og anvendelse som laegemiddel | |
DK602184D0 (da) | Imidazoquinoliner, deres fremstilling og anvendelse som laegemidler | |
DK42888D0 (da) | Arylthiadiazolylsulfonamider og derivater deraf, deres fremstilling og anvendelse som laegemiddel | |
DK421389A (da) | Aminomethyl-peptider, deres fremstilling og anvendelse som laegemidler | |
DK568289A (da) | 1-aminoalkyl-3-oxy-substituerede-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-oner, deres fremstilling og anvendelse som laegemidler | |
DK37787A (da) | 2,3-dioxabicyclooe3,3,0aaoctan-derivater og deres anvendelse som laegemidler | |
DK111887D0 (da) | Aromatiske omega-alkylimino-tetrahydro-6h-1,3-thiazin-6-on-derivater, deres fremstilling og anvendelse som laegemidler | |
DK14885D0 (da) | 1,4-dihydropyrazin, deres fremstilling og anvendelse som laegemidler | |
DK364589A (da) | Pyrido(3,4-f)pyrrolo(1,2-b)(1,2,5)-triazepiner, deres fremstilling og anvendelse som laegemidler |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHS | Application shelved for other reasons than non-payment |